Aleksandra Czyrek
9PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 26, 2026
Infigratinib is a weak inhibitor of the FGFR3-N540K mutant associated with hypochondroplasia.Vlad-Constantin Ursachi, Zuzana Feketova, Aleksandra Anna Czyrek
|Jan 10, 2026
Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes.Aleksandra A Czyrek, Daniel Krowarsch, Szymon Sidor
|Aug 27, 2025
Fibroblast Growth Factors in Lung Development and Regeneration: Mechanisms and Therapeutic Potential.Karolina Baran, Kamila Skrzynska, Aleksandra A Czyrek
|Apr 21, 2025
FGFR2 residence in primary cilia is necessary for epithelial cell signaling.Alexandru Nita, Sara P Abraham, Eman R Elrefaay
|Jul 29, 2023
FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs/ERKs and PI3K/AKT Signaling Pathway.Jakub Szymczyk, Aleksandra Czyrek, Jacek Otlewski
|Jun 21, 2023
FGF homologous factors are secreted from cells to induce FGFR-mediated anti-apoptotic response.Martyna Biadun, Martyna Sochacka, Radoslaw Karelus
Pageof 2
Frequent Collaborators
6 joint publications
Malgorzata Zakrzewska
5 joint publications
Jacek Otlewski
5 joint publications
Daniel Krowarsch
3 joint publications
Pavel Krejci
2 joint publications
Vlad-Constantin Ursachi
2 joint publications
Martyna Sochacka
2 joint publications
Karolina Baran
1 joint publications
Sara P Abraham
1 joint publications
Jakub Szymczyk
1 joint publications
Eliska Cizkova
